decisionhealth Newsletters, Part B News - 2017 Issue 11 (November)
Trump’s slow first-year start may be calm before the storm for health care industry
Subscribe or sign in to view the full article.
Article Overview
This article examines how the Trump administration’s first-year health care agenda was unfolding and why some observers viewed the pace of change as strategic rather than inactive. It discusses broad policy areas affecting the Affordable Care Act, federal health agencies, and the regulatory environment, making it relevant to health care leaders, policy analysts, and compliance professionals tracking federal developments.
Why This Topic Matters
The piece helps readers understand the direction of federal health policy and the possible implications for coverage, regulation, and agency leadership. It is useful for organizations monitoring ACA-related policy shifts, HHS/CMS leadership transitions, and broader changes that could affect health care operations and planning.
Article Sections
-
Overview of the administration’s health care approach
Introduces the article’s central theme about the pace and style of federal health policy action during the Trump administration. It frames the discussion around political strategy, agency direction, and early administrative priorities.
-
Policy direction and early administrative actions
Reviews broad health policy moves and the general regulatory posture of the administration. The section also touches on shifts away from some prior federal initiatives and the administration’s stated goals.
-
Congressional landscape and legislative constraints
Discusses how the status of major federal legislation and the congressional calendar shape what can move forward. It emphasizes the relationship between executive actions and pending legislative priorities.
-
Strategic pressure on ACA-related policy
Explores the idea that certain federal actions may be intended to influence negotiations and policy outcomes. The section focuses on ACA-related rulemaking and broader market effects without detailing technical provisions.
-
Post-Price leadership changes at HHS
Covers the transition in leadership after the resignation of the first HHS secretary and the potential direction of future appointments. It also addresses views on continuity across the department and related agency leadership.
What You Will Learn
- How analysts interpreted the Trump administration’s early health care strategy
- Which major federal health policy areas were driving congressional and agency attention
- Why ACA-related rulemaking drew attention from policy observers
- How leadership changes at HHS and CMS were being viewed in the broader policy context
- What kinds of regulatory and legislative issues were expected to shape the next phase of federal health policy
Who Should Read This
- Health policy analysts
- Health care executives
- Compliance professionals
- Government relations teams
- Medical practice administrators
- Payers and insurers
- Legislative affairs professionals
Subscribe or sign in to view the full article.



Quick, Current, Complete - www.findacode.com